Evotec SE

Business Description

Evotec SE is a Hamburg-based drug discovery and development company founded in 1993, operating across the United States, Europe, and beyond. The company works to create new treatments for a wide range of serious conditions, including cancer, diabetes, heart disease, kidney and liver disorders, and rare diseases, among others. Evotec partners with leading universities, research hospitals, and major pharmaceutical companies such as Bristol Myers Squibb and Novo Nordisk to advance its work, while also collaborating with biotechnology firms, patient groups, and venture capital investors.